» Articles » PMID: 27044812

Advancement in Contemporary Diagnostic and Therapeutic Approaches for Rheumatoid Arthritis

Overview
Date 2016 Apr 6
PMID 27044812
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

This review is intended to provide a summary of the pathogenesis, diagnosis and therapies for rheumatoid arthritis. Rheumatoid arthritis (RA) is a common form of inflammatory autoimmune disease with unknown aetiology. Bone degradation, cartilage and synovial destruction are three major pathways of RA pathology. Sentinel cells includes dendritic cells, macrophages and mast cells bound with the auto antigens and initiate the inflammation of the joints. Those cells further activates the immune cells on synovial membrane by releasing inflammatory cytokines Interleukin 1, 6, 17, etc., Diagnosis of this disease is a combinational approach comprises radiological imaging, blood and serology markers assessment. The treatment of RA still remain inadequate due to the lack of knowledge in disease development. Non-steroidal anti-inflammatory drugs, disease modifying anti rheumatic drugs and corticosteroid are the commercial drugs to reduce pain, swelling and suppressing several disease factors. Arthroscopy will be an useful method while severe degradation of joint tissues. Gene therapy is a major advancement in RA. Suppressor gene locus of inflammatory mediators and matrix degrading enzymes were inserted into the affected area to reduce the disease progression. To overcome the issues aroused from those therapies like side effects and expenses, phytocompounds have been investigated and certain compounds are proved for their anti-arthritic potential. Furthermore certain complementary alternative therapies like yoga, acupuncture, massage therapy and tai chi have also been proved for their capability in RA treatment.

Citing Articles

Bacillus subtilis (NMCC-path-14) ameliorates acute phase of arthritis via modulating NF-κB and Nrf-2 signaling in mice model.

Mazhar M, Naz S, Zulfiqar T, Khan J, Hilal F, Ghazanfar S Inflammopharmacology. 2025; .

PMID: 40009344 DOI: 10.1007/s10787-025-01676-3.


Complex rehabilitation of patients with rheumatoid arthritis.

Sagtaganov Z, Bekaryssova D Rheumatol Int. 2024; 44(9):1789-1793.

PMID: 39095530 DOI: 10.1007/s00296-024-05669-3.


Luobitong Potentiates MTX's Anti-Rheumatoid Arthritis Activity via Targeting Multiple Inflammatory Pathways.

Li Z, Zhang Q, Gao Y, Wan F, Wang Y, Hou B J Inflamm Res. 2024; 17:4389-4403.

PMID: 38994468 PMC: 11236762. DOI: 10.2147/JIR.S461093.


Cold Air Plasma Inhibiting Tumor-Like Biological Behavior of Rheumatoid Arthritis Fibroblast-Like Synovial Cells via G2/M Cell Cycle Arrest.

Ni L, Ding C, Deng J, Wu Z, Zhou Y Open Access Rheumatol. 2024; 16:75-85.

PMID: 38756916 PMC: 11096841. DOI: 10.2147/OARRR.S438536.


Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis.

Liu Y, Jiang P, Qu Y, Liu C, Zhang D, Xu B Heliyon. 2024; 10(6):e28127.

PMID: 38533025 PMC: 10963384. DOI: 10.1016/j.heliyon.2024.e28127.